PAH3 undervalued

This is an opportunity to ride the undervalued stock. below, please find my DD:

- Market Cap € 14.72B vs Total Equity €35.28B
- Net income €4.78B
- EBITDA: H1 2023 € 2.45B
- Dividend Yield: 5.28%
- Revenue € 4.54B
- PE: 3.85
- Basic EPS: € 12.59

My target price €100.